About the Company
Arcadia Biosciences (Nasdaq: RKDA) is a publicly traded American agricultural biotechnology headquartered in Davis, California focused on the development of traits to enhance crop quality and productivity. The company is partly owned by Moral Compass Corporation. It has developed a reduced-gluten and enhanced starch variety of wheat under the name GoodWheat. Arcadia also has a joint venture with Bioceres called Verdeca, which has developed and is commercializing HB4 technology in soybeans that gained FDA approval in 2017. HB4 soybeans have increased yield up to 30% while being more resistant to abiotic stress such as drought.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $RKDA News
Arcadia Biosciences, Inc. (NASDAQ:RKDA) Q4 2023 Earnings Call Transcript
Arcadia Biosciences, Inc. (NASDAQ:RKDA) Q4 2023 Earnings Call Transcript March 28, 2024 Arcadia Biosciences, Inc. isn't one of the 30 most popular stocks among hedge funds at the end of the third ...
Arcadia Biosciences (RKDA) Q4 Earnings Beat Mark, Sales Up Y/Y
Arcadia Biosciences, Inc. price-consensus-eps-surprise-chart | Arcadia Biosciences, Inc. Quote As of the end of 2023, RKDA’s ...
Arcadia Biosciences Inc RKDA
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Arcadia Biosciences Stock (NASDAQ:RKDA), Analyst Ratings, Price Targets, Predictions
Arcadia Biosciences Inc has a consensus price target of $7.25, established from looking at the 9 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC ...
Arcadia Biosciences: Q4 Earnings Snapshot
DALLAS — DALLAS — Arcadia Biosciences Inc. (RKDA) on Thursday reported a loss of $2.9 million in its fourth quarter. The Dallas-based company said it had a loss of $2.10 per share. Losses ...
Arcadia Biosciences, Inc. (NASDAQ:RKDA) Q4 2023 Earnings Call Transcript
Arcadia Biosciences, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon and welcome to the Arcadia ...
Arcadia Biosciences Inc RKDA
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Arcadia Biosciences, Inc. (RKDA) Q4 2023 Earnings Call Transcript
Good afternoon and welcome to the Arcadia Biosciences Fourth Quarter and Full Year 2023 Financial Results and Business Highlights Conference Call. At this time all participants are in a listen ...
Arcadia Biosciences Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Q4 2023 Arcadia Biosciences Inc Earnings Call
Good afternoon and welcome to the Arcadia Biosciences fourth quarter and full year 2023 financial results and business highlights conference call. (Operator Instructions) Please be advised that ...
Loading the latest forecasts...